L&C Bio
L&C Bio, established in 2011, is a corporate investor based in Seongnam City, Gyeonggi Province.
L&C Bio
L&C Bio, established in 2011, is a corporate investor based in Seongnam City, Gyeonggi Province. The firm develops regenerative medicine and medical devices for human tissue repair and transplants, and offers over-the-counter drugs, prescription medicine, and cosmetic products. It operates in the medical industry.
General information
Firm type
Corporate Investor
Year founded
2011
AUM
—
Location
Region
—
Country
—
City
Seongnam-si
Corporate office
Room 306~308, 605-607, Suntech City 1 Building, 474 Dunchon-daero Jungwon-gu
Frequently asked questions
What is L&C Bio?
L&C Bio is a corporate investor headquartered in Seongnam-si.
When was L&C Bio founded?
L&C Bio was founded in 2011.
Where is L&C Bio headquartered?
L&C Bio is headquartered in Seongnam-si.
What does Altss track for L&C Bio?
Altss maintains an OSINT-verified profile of L&C Bio covering investment focus (ESG policy, ticket size, target IRR, currency preference, regional focuses, industry focuses, technological focuses), team (service providers and advisors), deals (company deals and fund commitments), assets (real estate, public market positions, private companies, art and cultural holdings, philanthropy and foundations), and network (club memberships, associations, and event participation). Detailed values are available to Altss subscribers.
What is L&C Bio's website?
L&C Bio's public website is www.lncbio.co.kr. Verified contact details for principals and decision-makers are available to Altss subscribers.
What type of firm is L&C Bio?
L&C Bio is classified by Altss as a Corporate Investor.
How does Altss source intelligence on L&C Bio?
Altss combines OSINT (open-source intelligence) with regulatory filings, public disclosures, and licensed data partners. Source provenance is tracked to support compliance-ready research workflows.
How fresh is the Altss profile for L&C Bio?
L&C Bio's profile is part of Altss's continuous-refresh dataset, with a full update cycle at least every 30 days and priority changes applied as new information is verified.
Company types
Confirmed
Pipeline
Indicated
Negative
Industry focuses
Confirmed
Pipeline
Indicated
Negative
Regional focuses
Confirmed
Pipeline
Indicated
Negative
Technological focuses
Confirmed
Pipeline
Indicated
Negative
Get access to Altss to unlock details
Get accessInvestment stages
Confirmed
Pipeline
Indicated
Negative
Emerging interests
Hard exclusions
ESG policy
Direct deal program
Emerging manager LP program
Get access to Altss to unlock details
Get accessManager maturity preference
Confirmed
Indicated
Ticket size (USD M, min/max)
Preferred fund size (USD M, min/max)
Investment horizon (years, min/max)
Target IRR (%)
Max leverage
Liquidity terms
Currency preference
Get access to Altss to unlock details
Get accessPhilanthropy-only themes
Political donations
Service Providers & Advisors
| Category | Firm | Years Active | Primary Contact |
|---|---|---|---|
Company Deals
| Date | Company | Type | Sector | Geography | Role | Amount | Deal Lead | Co-investors | Insight |
|---|---|---|---|---|---|---|---|---|---|
Get access to Altss to unlock details
Get accessFund Commitments
| Date | Fund | Strategy | Geography | Role | Fund size | Vintage |
|---|---|---|---|---|---|---|
Club Memberships and Associations & Advisors
| Organization | Role | Since | Notes |
|---|---|---|---|
Get access to Altss to unlock details
Get accessEvent & Conference Participation
| Event | Role | Date | Location |
|---|---|---|---|
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: